Correct Answer: C. Arterial blood gas
This child presents with diabetic ketoacidosis (DKA) — evidenced by hyperglycemia (415 mg/dL), ketonuria (4+), altered mental status, tachypnea, and hemodynamic compromise (BP 70/50). The clinical triad of confusion, fast breathing, and dry mucous membranes is pathognomonic for DKA with metabolic acidosis. Before initiating ANY insulin or fluid therapy, the next best step is to obtain arterial blood gas (ABG) to quantify the severity of acidosis (pH, HCO3−, anion gap) and assess respiratory compensation. ABG determines the baseline acid-base status and guides the intensity of resuscitation. In Indian pediatric DKA protocols (IAP guidelines), ABG is the first investigation after basic labs (glucose, electrolytes, renal function) to risk-stratify severity (mild, moderate, severe) and tailor insulin dosing and fluid replacement. Without ABG data, you cannot safely proceed with insulin or aggressive fluid therapy — insulin dosing depends on pH (0.05–0.1 units/kg/hr in moderate-severe acidosis), and fluid rate depends on hydration status and osmolality. ABG also rules out concurrent respiratory pathology (aspiration, pneumonia) that may worsen outcomes in a hypotensive child.
Why the other options are wrong
A. Insulin bolus of 0.1 units/kg given — This is wrong because insulin bolus is contraindicated in DKA, especially in a hypotensive child (BP 70/50). Bolus insulin risks precipitous hypoglycemia and worsens hypokalemia (insulin drives K+ intracellularly). Current DKA protocols (IAP, ADA) mandate continuous insulin infusion (0.05–0.1 units/kg/hr) after ABG assessment and initial fluid resuscitation. Bolus dosing is an outdated approach that increases mortality. B. Insulin infusion at 0.1 units/kg/hour — This is wrong because insulin infusion must be deferred until ABG is obtained and initial fluid resuscitation is started. In a hypotensive child with severe acidosis, premature insulin therapy without baseline pH/HCO3− data risks overcorrection and cerebral edema. The sequence is: ABG → fluid bolus → electrolyte repletion → then insulin infusion. Starting insulin before assessing acidosis severity violates DKA management protocols and is unsafe. D. 2-3 L of normal saline over 1-3 hours — This is wrong because fluid volume and rate cannot be determined without ABG and electrolyte data. While this child is hypotensive and needs fluids, the rate depends on severity of acidosis, serum osmolality, and risk of cerebral edema (especially in children <5 years). Blindly infusing 2–3 L without knowing pH, HCO3−, and Na+ risks hyperchloremic acidosis or hyponatremia. ABG guides fluid strategy first.
High-Yield Facts
- DKA diagnosis requires: hyperglycemia (>250 mg/dL), ketonemia/ketonuria (3+ or 4+), and arterial pH <7.3 or HCO3− <15 mEq/L — ABG is the gold standard.
- DKA severity classification (IAP): mild (pH 7.25–7.30, HCO3− 15–18), moderate (pH 7.15–7.24, HCO3− 10–14), severe (pH <7.15, HCO3− <10) — ABG determines this and insulin dosing.
- Insulin infusion dosing in DKA: 0.05 units/kg/hr for mild, 0.1 units/kg/hr for moderate-severe — never bolus; start only after ABG + initial fluid resuscitation.
- Fluid resuscitation sequence: 10–20 mL/kg bolus of 0.9% NaCl over 1 hour (if hypotensive), then 0.45% NaCl at 5–10 mL/kg/hr — rate depends on ABG severity and osmolality.
- Cerebral edema risk (especially in children): occurs if osmolality corrected too rapidly or if hypotonic fluids used early; ABG guides osmolality-corrected Na+ and fluid tonicity.
- Hypokalemia paradox in DKA: total body K+ is depleted despite normal/high serum K+ at presentation; ABG + electrolytes guide K+ repletion (start 20–40 mEq/L once urine output confirmed).
Mnemonics
DKA Management Sequence: ABC Assess ABG first (pH, HCO3−, anion gap) → Bolus fluids (0.9% NaCl, 10–20 mL/kg/hr if hypotensive) → Continuous insulin infusion (0.05–0.1 units/kg/hr after ABG + fluids). Never insulin before ABG. DKA Severity by pH (Indian IAP guideline) Mild: pH 7.25–7.30 (insulin 0.05 U/kg/hr) | Moderate: pH 7.15–7.24 (insulin 0.1 U/kg/hr) | Severe: pH <7.15 (insulin 0.1 U/kg/hr + ICU). ABG is the key to this classification.
NBE Trap
NBE pairs insulin dosing options (bolus vs. infusion) with ABG to test whether students know the sequence of DKA management — many students incorrectly prioritize insulin therapy over baseline assessment. The trap is that both insulin options look reasonable (correct doses), but ABG must come first to guide all downstream decisions.
Clinical Pearl
In Indian pediatric practice, DKA is the leading cause of mortality in children with type 1 diabetes. The hypotensive presentation (BP 70/50) signals severe acidosis and risk of shock — ABG quantifies this urgency and prevents both under- and over-treatment. A child who "looks sick" needs ABG before insulin, not after.
_Reference: OP Ghai (Pediatrics) Ch. 10 (Endocrine Disorders); IAP DKA Management Guidelines 2015; Harrison Ch. 397 (Diabetes Mellitus)_